In a filing, ReShape Lifesciences Inc revealed its Chief Financial Officer STANKOVICH THOMAS unloaded Company’s shares for reported $12.0 on May 31 ’24. In the deal valued at $0.25 per share,48 shares were sold. As a result of this transaction, STANKOVICH THOMAS now holds 22,777 shares worth roughly $36215.43.
Price Performance Review of RSLS
On Tuesday, ReShape Lifesciences Inc [NASDAQ:RSLS] saw its stock jump 341.05% to $1.59. Over the last five days, the stock has gained 204.07%. ReShape Lifesciences Inc shares have fallen nearly -64.35% since the year began. Nevertheless, the stocks have fallen -85.13% over the past one year. While a 52-week high of $29.00 was reached on 01/13/25, a 52-week low of $0.34 was recorded on 03/31/25. SMA at 50 days reached $1.8673, while 200 days put it at $6.2991.
Levels Of Support And Resistance For RSLS Stock
The 24-hour chart illustrates a support level at 0.5233. On the upside, there is a resistance level at 2.8533. A further resistance level may holdings at 4.1167. The Relative Strength Index (RSI) on the 14-day chart is 63.53, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1397, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.96%. Stochastics %K at 16.68% indicates the stock is a buying.
How much short interest is there in ReShape Lifesciences Inc?
A steep rise in short interest was recorded in ReShape Lifesciences Inc stocks on 2025-03-14, growing by 0.28 million shares to a total of 0.37 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 82814.0 shares. There was a rise of 77.45%, which implies that there is a positive sentiment for the stock.
